What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Acceleration Bands

Score

-1.0

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 43 5.7 0.33% 0.42% 5.6% -3.2% -27.9%
SHORT 43 12.9 0.23% 0.27% 6.1% -4.9% -120.5%

Summary

Technical Analysis

Opthea (OPT.AX)


Indicator:

ACCELERATION BANDS


Last Signal:

BULLISH


Trading: BUY @ $2.67
Signal Strength: STRONG
Recommendation:

Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.


Opthea (ASX:OPT) is currently Oversold highlighting the potential for a short term trend reversal in the upward direction.



Acceleration bands serve as a trading envelope using an instrument’s typical volatility over a standard setting of 20 bars. The user may change the input (close) period length and multiplier factor.

Calculation: Acceleration Bands:
1) Upper band = ( High * ( 1 + 2 * (((( High – Low )/(( High + Low ) / 2 )) * 1000 ) * Factor )));
2) Lower band = ( Low * ( 1 – 2 * (((( High – Low )/(( High + Low ) / 2 )) * 1000 ) * Factor )));
3) Where Factor=0.001


PROFILE: Opthea (OPT.AX)


Stock Exchange: ASX
Company: Opthea
Ticker Codes: | OPT.AX | ASX:OPT |

About Opthea (ASX:OPT):

Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.

Top 10:

Acceleration Bands

Download
Company Close Change(%) Volume Value Signal
CII Ci Resources 1.34 16.1 7,170 -10.5 BEARISH
PNV Polynovo 1.94 11.8 11,074,353 -6.36 BEARISH
BFC Beston Global Food 0.09 10 383,135 -13.81 BEARISH
HFR Highfield Resources 0.67 9 22,865 -9.11 BEARISH
ISD Isentia 0.26 8.3 518,734 -1.43 BEARISH
MLX Metals X 0.11 8.2 3,754,499 -11.9 BEARISH
BVS Bravura Solutions 5.36 8.1 3,114,316 -8.52 BEARISH
MGX Mount Gibson Iron 0.91 7.1 3,615,391 -3.14 BEARISH
IMF IMF 3.81 6.7 2,751,384 -4.07 BEARISH
IMD Imdex 1.6 6 762,604 -3.76 BEARISH